Compare Zayla-Cream and ice compress on the level of stress, pain and cardiovascular response from due to needles insertion into arteriovenous fistula in hemodialysis.

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT2016050427744N1

Enrollment

150

Registered

2016-06-11

Start date

2016-05-21

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Arteriovenous fistula puncture-related complication in hemodialysis patients. Mechanical complication of vascular dialysis catheter

Interventions

Intervention 1: Interventions 1: At first, the patients complete a demographic questionnaire, based on it, the qualified patients will be enrolled in the study. At First week, the intensity of stress

Placebo

Treatment - Drugs

Interventions 1: At first, the patients complete a demographic questionnaire, based on it, the qualified patients will be enrolled in the study. At First week, the intensity of stress before injecti

Interventions 2: After one week, the intervention with Zaylapy cream will be done in which, in all patients, 10 minutes before inserting the needle in fistula, cream with the area of 5 cm2 will be ap

Interventions 3: In this group, 10 minutes before inserting the needle in fistula, ice will be placed around the fistula. Then the skin will be dried and disinfected and needle inserted in fistula. T

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: age over 18 years; being vigilant to time, place and persons at the time collecting the information; Hemodialysis patients who have at least two session of dialysis at week; patients who have at least three months past of their fistula embedding; absence of damaged skin in the desired positions; no known allergy to local anesthetics; without alcohol and drugs consumption; the minimum level of literacy; no history of mental illness with doctor approval. Exclusion criteria: Analgesic use in the past 24 hours; the patient's unwillingness to continue the study; the patient died.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Stress. Timepoint: After every intervention and before the fistula needle. Method of measurement: Stress visual analogue scale.;Pain. Timepoint: After every intervention and mmediately after the fistula needle. Method of measurement: Visual analoug scale.;Blood pressure. Timepoint: After every intervention and before and after the fistula needle. Method of measurement: Stigno monometer.;Pulse. Timepoint: After every intervention before and after the fistula. Method of measurement: Analog clock with seconds.	—

Measure

Time frame

Stress. Timepoint: After every intervention and before the fistula needle. Method of measurement: Stress visual analogue scale.;Pain. Timepoint: After every intervention and mmediately after the fistula needle. Method of measurement: Visual analoug scale.;Blood pressure. Timepoint: After every intervention and before and after the fistula needle. Method of measurement: Stigno monometer.;Pulse. Timepoint: After every intervention before and after the fistula. Method of measurement: Analog clock with seconds.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactZiba Ghoreishi

Shahroud university of medical sciences

ghoreyshi@shmu.ac.ir+98 23 3239 3811

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026